5. QUESTION TO BE ASKED BEFORE BIRTH
What is the expected gestational age?.
Is the amniotic fluid clear?
Are there any additional risk factors?
What is our umbilical cord management plan?
ANTENATAL COUNSELLING :
6. TEAM BRIEFING :
Team members : -
i. No risk : 1 qualified person skilled in PPV & initial steps of newborn care
ii. High risk : >= 2 skilled people
iii. Multiple pregnancy : 2 resuscitation teams
7. Team work :
i. Know environment
ii. Anticipate and plan
iii. Assume leadership
iv. Communicate effectively
v. Delegate workload optimally
vi. Allocate wisely
vii. Use all available information and resources
viii. Call for help when needed
ix. Professional behaviour
8. EQUIPMENT CHECK :
Warmth :
1. Radiant warmer with firm padded
resuscitation surface : switch on 20
mins before delivery (100%)
2. 2 clean dry cloth pre-warmed
3. Switch off fan/ AC and close
windows
4. Re-closable, food grade plastic bag
(size : 1 gallon) or plastic wrap
5. Transport incubator
Bassinet
Quartz rod
Skin
probe
Control
panel
Heater output display
Heater output
control knobs
Temperature selection panel
Temperature
display
Mode
selector
10. Breathing :
1. AMBU bag
2. Face masks with cushioned rims (term and
preterm sizes)
3. Oxygen source, Compressed air source,
Oxygen blender with flowmeter (10L/min) +
tubing
4. Pulse oximeter and oximeter probe
5. Laryngoscope with straight blades no. 00, 0,
1
6. Extra bulbs and batteries
7. ETT 2.5, 3.0, 3.5, 4.0 mm internal diameter
(uncuffed)
8. Stylet
9. Scissors, tape
10. Alcohol sponges
11. Capnograph
12. Laryngeal mask airway
11. WEIGHT (GMS) GESTATIONAL AGE (WEEKS) ETT SIZE (MM ID) SUCTION CATHETER SIZE
< 1000 < 28 2.5 5 F or 6 F
1000 – 2000 28 – 34 3 6 F or 8 F
13. SELF INFLATING BAG – free flow
O2 can be given by it’s open tail
reservoir
FLOW INFLATING BAG – free flow
T PIECE
RESUSCITATO
R – free flow
O2 can be
16. Circulation :
1. Epinephrine 1 : 10,000 dilution (0.1mg/ml)
2. Isotonic crystalloids (NS or RL) for dilution and volume expansion – 100ml / 250 ml
3. Dextrose 10% 250ml
4. NS for flushes
5. UVC supplies (Umbilical catheters 3.5 F, 5 F)
6. IV cannula, tape
7. 1 ml, 2 ml, 3 ml, 5 ml, 10 ml, 20 ml, 50 ml syringes
8. 3 way stopcock
9. Sterile gloves
10. Needles 25 G, 21 G, 18 G
17. Others :
1. Vitamin K
2. Cord clamp and sterile blade/ scissors
3. Sterile gauze pieces, gloves, personal protections
19. ROUTINE CARE :
T : Term
T : Good tone
R : Vigorous cry or good respiration
1. Delayed cord clamping
2. Warmth : skin to skin contact associated
with breast-crawl/ radiant warmer
3. Clear airway if necessary
4. Dry : head, chest + abdomen, limbs
(flexures)
5. Observe baby mother side
20. T : Preterm / Term
T : Poor tone
R : Poor cry / no cry
INITIAL STEPS
1. Warmth : radiant warmer
2. Dry : head, chest + abdomen, limbs (flexures)
3. Stimulate : 2 flicks at sole (tactile stimulus)
4. Position : Rose position/ sniffing the morning air position
5. Airway
6. Suction : clear airway by wiping mouth and nose ; suction
mouth (sweeping) followed by nose (twisting)
7. Check heart rate (6sec x 10), gasping, apnoea
Normal with no laboured breathing or persisting
cyanosis : Routine care
Normal with laboured breathing or persisting cyanosis :
WPS with SpO2 monitoring and supplemental O2 (O2 tubing/
masking, BMV, T piece resuscitator) ; consider CPAP ; post
resuscitation care
Abnormal : further resuscitation
21. POSITIVE PRESSURE VENTILATION :
Apnoea
Gasping
HR < 100bpm
SpO2 < target despite free flow O2 or CPAP
Start BMV at room air (>= 35 weeks) or 21-30%
O2 (<35 weeks) at 10L/min flow for 30 sec at the
rate SQUEEZE, 2, 3
Check for chest raise(first 15 sec), HR, SpO2
Chest raise absent or minimal : ventilation
corrective steps
HR between 60-100 bpm : PPV
HR >100 bpm : Post resuscitation care
SpO2 < target but HR good : adjust O2 flow/min
PIP : 20 – 25 cm H2O
PEEP : 5 cm H2O
25. ALTERNATIVE AIRWAYS :
ENDOTRACHEAL INTUBATION
LARYNGEAL MASK AIRWAY
Laryngoscope lift in rocking motion
Attempt intubation for 30 sec only
Measure for length of insertion NTL (nasal
septum to ear tragus + 1 cm)
Proper tip placement :
• CO2 detector by calorimetric and
capnographs
• Audible equal breath sounds near axillae
during PPV
• Symmetrical chest movements
• Little or no air leak from mouth during PPV
• Decreased or absent air entry over stomach
• Chest X-ray : tip seen mid-trachea between
1st
and 2nd
vertebrae, above carina
27. CO2 DETECTOR BY INTUBATION (within 8-10 breaths) :
CALORIMETRIC METHOD
28. DOPE MNEUMONIC
D Displaced ETT
O Obstructed ETT (murphy’s eye can serve as second tip
temporarily)
P Pneumothorax
E Equipment failure
SUDDEN DETERIORATION AFTER INTUBATION:
ENDOTRACHEAL INTUBATION LARYNGEAL MASK AIRWAY
Subglottic airway device Supraglottic airway device
Difficult to insert Easy to insert
Used for intubation, stabilization of
diaphragmatic hernia, suction of
tracheal secretions, surfactant
therapy (INSURE)
Keeps airway open but can’t ventilate
can’t intubate; placed after 2 attempts
of ETT insertion or suspecting
congenital airway anomaly
29. CHEST COMPRESSIONS :
Persisting HR < 60 bpm after 30 sec of PPV with
effective ventilation
(ideally effective PPV via ETT or LMA to be given for
30 sec)
(s/o very low blood oxygen levels, significant
acidosis, poor coronary perfusion)
Chest compressions started only after securing
good ventilation evidenced by chest
movements with ventilation
30. Stand : side till ETT placed (100% O2) and then
head end
Position : 2 thumbs over lower 1/3rd
of sternum ;
other 4 fingers encircling chest and supports
vertebrae
NEVER ON XIPHOID STERNUM : LIVER INJURY
Depth : 1/3rd
of chest AP diameter
Never lift thumb away from surface
Rhythm : 1 and 2 and 3 and breathe and 1 and 2
and 3 and breathe and …
3 compressions 1 ventilation every 2 seconds =
90 compressions and 30 ventilations per minute
Don’t squeeze ; only push thumbs downwards
Assess after 60 seconds ; HR and CO2 detector
changing colour
Complications : injury to heart, lung(s), liver, ribs
Stop after HR > 60 bpm with good ventilation
31. MEDICATIONS :
30 seconds PPV with good ventilation
60 seconds chest compressions + good PPV (100% O2)
Epinephrine also given only after securing
good ventilation evidenced by chest
movements with ventilation
Vascular & cardiac stimulant
Constriction of blood vessels outside heart
Increases coronary blood flow and perfusion
Increases cardiac contractility
32. EPINEPHRINE SUMMARY
CONCENTRATION
1 : 10,000 = 0.1 mg/ml
(1 ml of 1 : 1000 in 9 ml NS)
ROUTE
Intravenous
Intraosseous
Endotracheal
PREPARATION
IV / IO : 1 ml syringe labelled
epinephrine – IV
ET : 3 – 5ml syringe labelled
epinephrine – ET only
DOSE
IV / IO : 0.2 ml/kg (0.o2 mg/kg)
ET : 1 ml/kg (0.1 mg/kg)
ADMINISTRATION
IV/ IO : rapid with 3 ml NS flush
ET : rapid with PPV
33. H T
HYPOVOLEMIA TOXINS
HYPOXIA TAMPONADE (CARDIAC)
HYDROGEN IONS (ACIDOSIS) TENSION PNEUMOTHORAX
HYPO/HYPERKALEMIA THROMBOSIS (CORONARY)
HYPOTHERMIA THROMBOSIS (PULMONARY)
HYPOGLYCEMIA TRAUMA
Stop resuscitation : Absence of detectable HR (APGAR 0) after 20 minutes of
resuscitation
34. VOLUME EXPANDERS :
INDICATED WHEN BABY NOT RESPONDING TO RESUSCITATION STEPS AND
SHOWS SIGNS OF SHOCK OR HISTORY ACUTE BLOOD LOSS
VOLUME EXPANDER
Volume expander of choice Crystalloid fluid (0.9% NaCl)
Volume replacement in
severe foetal anaemia
Packed RBC (cross matched to mother)
Emergency : non cross matched O –ve blood
Dose 10 ml/kg bolus over 5-10 mins
+/- 10 ml/kg
(slower infusion pre-terms <30 weeks GA d/t ICH)
Route Umbilical venous catheter ; intraosseous
Preparation 30-60 ml syringe labeled
35. UMBILICAL VEIN CATHETERISATION :
1. Sterile technique
2. Appropriate size UVC filled with 3-10 ml sterile
water and 3 way stop cock used to lock it
3. Cord cleaned with antiseptic solution
4. Loose tie tied at base of cord or adjacent skin
5. Cut straight 1-2 cm above skin line
6. Identify vein and insert catheter 2-4 cm until free
flow of blood obtained
7. Open stopcock and gently aspirate
8. Secure 1 cm away from aseptic site
36. INTRAOSSEOUS NEEDLE INSERTION :
1. Sterile technique
2. Flat surface of leg (2 cm below and 2 cm medial to
tibial tuberosity)
3. Needle held perpendicular and advanced till
change in resistance or ‘pop’ sound heard
4. Needle should be firm and not wiggly after
insertion
5. Monitor the site
41. PREMATURITY :
1. Thin skin, low s.c. fat, large surface area relative to body mass
2. Immature brain development, immature blood vessels to brain
3. Immature lungs lacking surfactant, weak chest muscles, flexible ribs
4. Weak muscles
5. Rapid heat loss : minimal metabolic response to cold
6. Infection, chorioamnionitis (preterm labour), immature immune system
(pneumonia, sepsis, meningitis)
7. Fragile blood vessels in brain
8. Small blood volume
9. Immature tissues : damaged by excess oxygen
10. Limited metabolic reserves and immature compensatory mechanisms :
increases risk of hypoglycemia
42. PREMATURITY : ADDITIONAL RESOURCES NEEDED if < 32 WEEKS
GA
1. Polythene wrap / food grade re-closable 1 gallon plastic bag , hat
2. Thermal mattress
3. Servo controlled radiant warmer
4. Oxygen blender , oximeter with appropriate sized sensor
5. ECG monitor and 3 leads
6. PEEP and CPAP ; T piece resuscitator or flow inflating bag
7. Preterm sized resuscitation mask, size 0 / 00 laryngoscope , ETT (2.5 / 3 mm)
8. Surfactant if <30 weeks GA
9. Pre warmed transport incubator with blended oxygen and pulse oximeter
43. PREMATURITY : RESUSCITATION
1. Warmth : maintain axillary temperature between 36.50
– 37.50
Celsius
2. Spontaneous breathing : CPAP
3. If PPV required : 20 – 25 cm H2O pressure inspiratory pressure given
4. If face mask used : 30 – 40 cm H2O inspiratory pressure given
5. If PPV required use devise that provides PEEP : 5 cm H2O
6. Consider surfactant in respiratory distress or extreme preterm
(alternative is CPAP)
7. O2 supply according to saturation reading in monitor
8. <35 weeks GA : initiate resuscitation with 21 – 30 % O2
44. PREMATURITY : PRECAUTIONS
1. Handle gently
2. Do not position legs higher than head (Trendelenburg position)
3. Avoid excess pressure delivery by CPAP or PPV : pneumothorax , ICH
4. Use pulse oximeter and blood gas levels to monitor and adjust
ventilation and O2 concentration
5. Do not rapidly infuse IV fluids
6. Monitor temperature
7. Monitor blood glucose
8. Monitor apnoea, bradycardia
46. PNEUMOTHORAX :
Contraindication for PPV, especially preterm , babies with lung
abnormalities and meconium aspiration syndrome
Severe respiratory distress, bradycardia, desaturation : TENSION
PNEUMOTHORAX
Signs : no improvement in spite of resuscitation and sudden distress
Rapid screening test : Transillumination
Diagnosis : Chest x-ray
Treatment : Thoracostomy tube placement
47. PLEURAL EFFUSION :
Oedema, infection, leakage from lymphatic
system
Diagnosis made before birth by ultrasound
H/o foetal anaemia, twin to twin transfusion,
cardiac arrhythmias, congenital heart disease,
congenital infection, genetic syndromes
RESPIRATORY DISTRESS + GENERALISED
OEDEMA : Hydrops Foetalis (suspect pleural
effusion)
Diagnosis : Chest X-ray
Treatment : Intercostal Drainage
48. THORACOCENTESIS :
Confirm side of aspiration
Position : shoulder roll placed to displace air superiorly
Site of puncture pneumothorax : 4th
ICS anterior intercostal line or 2nd
ICS
midclavicular line
Site of puncture pleural effusion : 5th
or 6th
ICS along posterior axillary line
Sterile procedure
Needle : 18-20 G percutaneous catheter over needle 900
to chest wall and top
of rib / butterfly needle
Direction : direct upwards (pneumothorax) , direct downwards (pleural
effusion)
Attach syringe and 3 way stopcock
Repeat X-ray to see the residual pneumothorax or pleural effusion
49. AIRWAY OBSTRUCTION :
Thick secretions : meconium, blood, mucus,
vernix ; do ventilation corrective steps ; increase
suction to 80-100 mm Hg
Robin sequence : micrognathia + glossoptosis
Put baby in prone position – tongue moves forward
and open airway (OR)
Insert small ETT 2.5 mm through nose with tip
placed deep in posterior pharynx, past base of
tongue, above vocal cords NOT INSERTED INTO
TRACHEA (relieves airway obstruction)
Face mask ventilation with ETT in place
LMA maybe helpful in failed ventilation
53. What is a normal newborn….?
Birth weight 2.5 kg or more
Gestational age 37 weeks or more
Birth weight appropriate for age
1min APGAR >7
Infant doesn’t need any resuscitation
Infant did not suffer from any postnatal significant illness
Mother did not suffer from any serious complications
54. PREPARATION BEFORE BIRTH OF BABY
Review maternal records for
o maternal age
o Previous pregnancy outcomes
o weight gain in pregnancy,
o consanguinity,
o History of any medical disease,
55. o Obstetric complications
o Medications taken (native medicines, drugs, abortifacients),
o Sociodemographic background including alcohol and drug use,
o Pregnancy screening tests,
o Ultrasound reports
56. Prenatal screening test results should be reviewed and documented on the infant’s chart at the
time of delivery.
Maternal prenatal screening tests
• Blood type, Rh, and antibody screen
• Hepatitis B surface antigen (HBsAg)
• Serologic test for syphilis
• Human immunodeficiency virus (HIV)
• Glucose tolerance test
• Antenatal testing results, including serum markers for aneuploidy, and ultrasonography
results
57. CARE AT BIRTH
The transition from fetal life to extrauterine life involves dramatic changes in
physiology.
During this period, the infant’s pulmonary vascular resistance decreases
Blood flow to the lungs is greatly increased,
Oxygenation improves rapidly,
Ductus arteriosus begins to constrict or close
58. COMMON SIGNS OF DISORDERED TRANSITIONING
• Poor cry at birth/poor respiratory efforts .
• Poor tone and movements .
• Poor color/perfusion/heart rate .
• Respiratory distress ± cyanosis.
If the neonate requires only initial steps of resuscitation (tactile stimulation or short positive-
pressure ventilation)- observation near the mother may be considered.
59. AVOID SEPARATION OF NORMAL WELL BABY FROM MOTHER.
Avoid separation of the mother and the infant especially during the first hour of
life
To promote immediate initiation of breastfeeding and early bonding through skin-
to-skin contact.
Healthy newborns must room-in with their mothers.
Delay detailed examination (including taking birth weight), to allow the
opportunity to breastfeed, immediately after birth
60. Security systems to protect newborns
• Identification (ID) bands with matching numbers are placed on the
newborn and the mother, as soon after birth as possible.
• Transport of infants between areas should not occur until ID banding has
been confirmed.
• All staff are required to wear a picture ID badge, and parents should be
instructed to allow the infant to be taken only by someone wearing an
appropriate ID badge.
61. ROUTINE CARE
Physical assessments, administration of medications, and routine laboratory tests should occur
in the mother’s room or close to her room
Infant’s weight, head circumference, and length are recorded. On the basis of these
measurements, the infant is classified as appropriate for gestational age (AGA), small for
gestational age (SGA), or large for gestational age
If the gestational age of the infant is uncertain, an assessment of the gestational age can be
performed using the expanded New Ballard Score
The infant’s temperature is stabilized with skin-to-skin contact with the mother at birth. The
baby should be wrapped in cotton wraps, caps, socks, and mittens.
62. FEEDING
Breastfeeding should be started at the earliest given opportunity, preferably during
the first golden hour
Exclusive breastfeeding for the first 6 months of a new born’s life
Mothers should initiate breastfeeding as soon as possible after delivery, preferably
in the delivery room
The infant should be fed on demand, 8 to 12 times per day during the birth
hospitalization
63. SKIN CARE
The first bath is given with warm tap water and nonmedicated soap
Avoid the routine dip baths till the baby is in hospital due to the risk of infections.
Daily sponging should be done at least once a day with clean water.
Each eye should be cleaned from the inner to the outer canthus using separate
sterile swabs (one for each eye) dipped in sterile or distilled water.
Routine daily cleaning is not recommended.
64. UMBILICAL CORD CARE
Dry cord care is generally sufficient.
Routine application of antibiotics and antiseptics should be avoided.
Evidence suggests that the use of 7.1% chlorhexidine is justified in community settings
with high neonatal mortality rate and unclean cord practices.
Keeping the cord dry also promotes earlier detachment of the umbilical stump.
The diaper should be folded below the umbilical cord to avoid the risk of infection.
65. MEDICATIONS
A single, intramuscular dose of vitamin K1 (phytonadione; 1 mg IM) should be given to all
newborns before 24 hours of age to prevent vitamin K deficiency bleeding
VACCINATIONS
Hepatitis B: Administration of the first dose of hepatitis B vaccine is recommended for all
infants during the newborn hospitalization, even if the mother’s HBsAg test is negative
Hepatitis B vaccine is administered by 12 hours of age when the maternal HBsAg is positive or
unknown.
Infants of HBsAg-positive mothers require hepatitis B immune globulin in addition to vaccine
66. BCG vaccine is administered in most Asian countries.
It is known to protect against serious forms of tuberculosis.
The vaccine is given intradermal on the leftarm.
Oral polio vaccine (OPV) zero dose is mandatory in India.
The risk of vaccine-associated polio due to live strains is not noted.
67. ROUTINE ASSESSMENTS
The physician should perform a complete physical examination within 24 hours
of birth.
The physical examination includes observation of the newborn’s general
appearance, posture, and movements followed by head-to-toe examination.
We have to palpate the femorals and examine the genitalia, hips, and spine for any
deformity or malformation.
Always check for vital signs, including respiratory rate, heart rate, and
temperature, every 8 to 12 hours and record them.
68. Each urine and stool output is recorded in the infant’s chart.
The first urination should occur by 48 hours of age.
The first passage of meconium is expected by 24 hours of age.
Delayed urination or stooling is a cause for concern and must be investigated.
Weights are recorded in the infant’s chart.
Weight loss in excess of 7% to 10% of birth weight should be investigated. Look for
attachment and positioning of the neonate.
Lactation support is important to help determine further management.
69. SCREENING
1. Screening for neonatal sepsis risk
All newborns should be screened for the risk of infections from the mother
gestational age <37 weeks,
Maternal intrapartum temperature ≥100.4°F (38°C)
Rupture of membranes >18 hours,
Signs of chorioamnionitis.
70. Glucose screening
Infants should be breastfed early and frequently to prevent
hypoglycemia
Healthy normal newborns require no glucose screening
Infants of diabetic mothers, infants who are SGA or LGA, and
preterm infants should be screened for hypoglycemia in the
immediate neonatal period
71. Newborn metabolic screening
Indian Academy of Pediatrics (IAP) recommends routine screening for congenital
hypothyroidism.
In populations in whom glucose-6-phosphate dehydrogenase (G6PD) is common, screening is
advised by IAP. Many state governments and private sector hospitals screen for various
metabolic disorders. There is no national recommendation.
Routine collection of the specimen is between 48 and 72 hours of life.
72. Bilirubin screening
Before discharge, all newborns should be screened for the risk of subsequent development of
significant hyperbilirubinemia.
Risk factors for developing significant hyperbilirubinemia include hemolytic disease,
prematurity, G6PD deficiency, ,presence of cephalohematoma or significant bruising, exclusive
breastfeeding with weight loss, and a sibling history of phototherapy treatment.
Jaundice during the first 24 hours of life is considered pathologic and warrants a total serum
bilirubin level.
The bilirubin result should be plotted and interpreted on an hour-specific nomogram to
determine the need for phototherapy
Parents should be given verbal and written information about newborn jaundice.
73. Hearing screening
1. Routine screening for hearing loss in newborns is mandated in most states . The
IAP also recommends universal screening for hearing impairment.
2. Verbal and written documentation of the hearing screen results should be provided
to the parents with referral information when needed.
3. Parents must be explained that a ‘retest’ hearing screen does not mean that the
baby is hearing impaired. The need to follow up should be clearly explained and
documented.
74. Critical congenital heart disease screening
Screening for critical congenital heart disease (CCHD) using pulse oximetry
The pulse oximetry screening should be performed in all neonates after 24 hours of age or prior to discharge,
whichever is earlier.
CCHDs are congenital heart defects requiring surgery or catheter intervention within the first year of life.
75. In Pulse oximetry screening (of preductal and postductal oxygen
saturations) is most likely to help diagnose the following seven
CCHDs:
a. Hypoplastic left heart syndrome
b. Pulmonary atresia
c. Tetralogy of Fallot
d. Total anomalous pulmonary venous return
e Transposition of the great arteries f. Tricuspid atresia
g. Truncus arteriosus
76. Predischarge checklist
• Adequacy of oral intake:
• This includes a minimum of eight feeds per day,
Change of meconium to transitional green/yellow stool by the second to third day
• one to two urine voids on the first 2 days and six to eight per day thereafter.
No significant jaundice; follow-up for jaundice should be scheduled and parents
educated on its importance.
• The infant’s vital signs are documented to be within the normal ranges (with
appropriate physiologic variations) and stable
77. • Clinical course and physical examination reveal no abnormalities that require continued
hospitalization.
• Maternal and infant laboratory tests have been reviewed.
• Vitamin K, BCG, OPV, and hepatitis B have been given.
• Screening protocol (metabolic, hearing, CCHD) as per institution has been completed.
78. • Parents should be explained regarding immunization schedule with the date of next
immunization visit mentioned on the discharge card.
• Parental competency to care for the newborn has been demonstrated.
• Family, environmental, and social risk factors have been assessed.
• A primary care physician has been identified.
• Danger signs and signs of illness including fever, irritability, lethargy, poor feeding
pattern, difficulty in breathing, rapid breathing, or presence of abnor- mal
movements have been explained to the parents.
79. FOLLOW-UP
For infants discharged before 48 hours of life, an appointment with a health care
provider should be arranged within 48 hours of discharge. If early follow-up
cannot be ensured, early discharge should be deferred.
For newborns discharged between 48 and 72 hours of age, outpatient follow-up
should be within 2 to 3 days of discharge. Timing should be based on the risk for
subsequent hyperbilirubinemia, feeding issues, or other concerns.
80. The follow-up visit is designed to perform the following functions:
Assess the infant’s general state of health including weight, hydration,
Degree of jaundice and identify any new problems.
Look for danger signs.
Review feeding patterns; encourage and support breastfeeding.
Review the adequacy of stool and urine patterns.
Provide referral for lactation support if feeding and elimination patterns are not reassuring.
81. Assess the quality of mother–infant bonding
Reinforce maternal or family education.
Review results of any outstanding laboratory tests.
Perform screening tests in accordance with state regulations.
Assess parental well-being and screen for maternal postpartum depression.